Female Contraception – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Female Contraception – Drugs In Development, 2024 report and make more profitable business decisions.
Contraception (birth control) prevents pregnancy by interfering with the normal process of ovulation, fertilization, and implantation. There are many contraceptive methods which include implants and injections, intrauterine devices (IUDs), pills and vaginal rings, barrier methods, sterilization, and “natural” methods. Contraception generally works by preventing sperm from reaching and fertilizing an egg (barrier and IUD methods), preventing an egg from being released every month (hormones), blocking the reproductive function (sterilization), and preventing a fertilized egg from implanting in the uterus (hormones).
The Female Contraception drugs in development market research report provide comprehensive information on the therapeutics under development for Female Contraception, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Female Contraception and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Female Contraception | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 44 molecules, with 37 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Female Contraception therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Female Contraception pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Female Contraception treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Adare Pharma SolutionsAdocia SAS
Anelleo Inc
ASKA Pharmaceutical Holdings Co Ltd
Brigham and Women's Hospital
Central Drug Research Institute
Dare Bioscience Inc
DelSiTech Ltd
Evestra Inc
Evofem Biosciences Inc
Exeltis Pharmaceuticals Holding SL
Fuji Pharma Co Ltd
Hervana Ltd
Hyundai Pharma Co Ltd
Indian Council of Medical Research
Innovagyn Inc
InSilico Medicine
Insud Pharma
International Partnership For Microbicides
Lyndra Therapeutics Inc.
MedinCell SA
Micron Biomedical Inc
Mithra Pharmaceuticals SA
Monash University
Mucommune LLC
Myovant Sciences Ltd
Navad Life Sciences Pte Ltd
Organon & Co
Orion Biotechnology Canada Ltd
Schrodinger Inc
Teva Pharmaceutical Industries Ltd
The Population Council Inc
VaRi Bioscience GmbH
Viatris Inc
Viramal Ltd
Yaso Therapeutics Inc
YourChoice Therapeutics Inc
ZabBio Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Female Contraception reports